Invention Grant
- Patent Title: Platform drug delivery system utilizing crystal engineering and theanine dissolution
-
Application No.: US15080029Application Date: 2016-03-24
-
Publication No.: US09603938B2Publication Date: 2017-03-28
- Inventor: Harry G. Brittain , Philip V. Felice
- Applicant: THEAPRIN PHARMACEUTICALS INC.
- Applicant Address: US NY Hauppauge
- Assignee: THEAPRIN PHARMACEUTICALS INC.
- Current Assignee: THEAPRIN PHARMACEUTICALS INC.
- Current Assignee Address: US NY Hauppauge
- Agency: Notaro, Michalos & Zaccaria P.C.
- Main IPC: A61K38/12
- IPC: A61K38/12 ; A61K47/48 ; A61K31/704 ; A61K31/13 ; A61K31/137 ; A61K31/192 ; A61K31/198 ; A61K31/277 ; A61K31/4045 ; A61K31/4164 ; A61K31/4196 ; A61K31/426 ; A61K31/43 ; A61K31/445 ; A61K31/4745 ; A61K31/48 ; A61K31/496 ; A61K31/4985 ; A61K31/506 ; A61K31/522 ; A61K31/536 ; A61K31/545 ; A61K31/546 ; A61K31/549 ; A61K31/573 ; A61K31/635 ; A61K31/7048 ; A61K31/7072 ; A61K47/18 ; A61K31/4453
Abstract:
A method of making a water-soluble doxorubicin-theanine cocrystal composition. The method includes the steps of providing a quantity of doxorubicin, adding a quantity of a theanine enantiomer to the quantity of doxorubicin to form a mixture of the quantity of doxorubicin and the enantiomer of theanine, wetting the mixture, and grinding the mixture for a length of time sufficient to produce a dried crystalline mass.
Public/Granted literature
- US20160263229A1 PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION Public/Granted day:2016-09-15
Information query
IPC分类:
